Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
China flag China · Delayed Price · Currency is CNY
14.08
+0.21 (1.51%)
Sep 30, 2026, 3:04 PM CST

SHE:002393 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
1,3021,3921,3361,1531,1471,092
Revenue Growth
-1.58%4.18%15.88%0.56%5.00%-4.29%
Gross Profit
673.05747.08712.11665.06636.08618
Operating Income
113.1793.4669.41118.661.0528.66
Net Income
151.69416.28184.53361.8393.61122.11
Earnings Per Share
0.491.350.601.170.300.40
EPS Growth
-64.55%125.00%-48.57%284.29%-23.87%1238.26%

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Northern China
482.83579.59497.76552.77496.66446.15
Northeast China
54.9753.8861.1720.1725.0725.57
East China
308.97322.92307.6224.86270.81241.41
South Central China
221.85228.87280.25202.74160.64187.33
Southwest China
141.66119.22113.4390.83122.7126.51
North-West China
88.784.8573.5558.9166.9560.95
Export
3.152.682.382.753.754.02
Total
1,3021,3921,3361,1531,1471,092

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
2,3502,5582,3692,2201,9941,652
Total Debt
12.9445.4951.0133.4245.0834.74
Net Cash (Debt)
2,3372,5132,3182,1871,9491,617
Net Cash Growth
11.82%8.39%6.01%12.23%20.49%4.86%
Net Cash Per Share
7.528.157.547.056.325.28

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
133.47247.588.26200.01331.38196.34
Capital Expenditures
-34.94-37.46-53.75-61.72-40.91-88.24
Free Cash Flow
98.53210.0434.51138.29290.47108.1
Free Cash Flow Growth
73.00%508.58%-75.04%-52.39%168.71%-

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
51.69%53.67%53.30%57.68%55.48%56.60%
Operating Margin
8.69%6.71%5.20%10.29%5.32%2.62%
Pretax Margin
11.46%32.73%16.16%36.44%10.32%12.56%
Profit Margin
11.65%29.90%13.81%31.38%8.16%11.18%
FCF Margin
7.57%15.09%2.58%11.99%25.33%9.90%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
1.0000.7500.2920.3570.1790.179
Dividend Per Share Growth
191.43%157.11%-18.31%99.94%0%200.17%
Dividend Yield
7.10%4.32%2.11%2.51%1.56%1.56%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
28.8313.3624.4513.2941.8532.29
Forward PE
-18.1818.1818.1818.1818.18
P/FCF Ratio
44.0326.48130.7234.7813.4936.48
PS Ratio
3.334.003.384.173.423.61